Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
There are many available technologies in the ophthalmologist’s toolkit for the corneal practice. EyeWorld spoke to three ophthalmologists to get their thoughts on advanced imaging options in cornea, including some of the newer technologies.
➤ Phase 3 clinical program complete for epithelium-on crosslinking treatment ➤ NDA submitted for oral Stargardt disease therapy ➤ Preclinical data shared for investigational TED therapy ➤ Three new clinical programs to begin for inherited retinal diseases ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ First patient dosed in Phase 3 trial evaluating cenegermin for PCED ➤ First patient dosed in Phase 3 study for Stargardt treatment ➤ First patient randomized into registrational trial for first-in-class dry eye therapy ➤ FDA clears new software for retinal imaging machine ➤ Company news ➤ ASCRS news and events ➤ EyeWorld article of the week
➤ Keep up with ASCRS Annual Meeting coverage with EyeWorld Onsite ➤ Positive topline results from Phase 3 trial for TED drug with new delivery method ➤ FDA expands dosing interval for wet AMD, DME treatment ➤ IDE granted to noninvasive bioelectric stimulation therapy for dry AMD ➤ First patients dosed in Phase 3 corneal cell therapy ➤ TED investigational treatment fails to meet primary endpoint ➤ OTC eye drop recall after FDA enforcement report cites sterility concerns ➤ ASCRS news and events
Epithelial basement membrane dystrophy (EBMD) is a common corneal issue. Two experts discussed how this might present in patients and the number of treatment options available to address the condition, with surgeons often needing to use several different strategies.
“As we advance in medicine, the next frontier will be getting a true picture of the state of the patient—genetics, environment, and lifestyle—and using this to find the correct diagnosis and treatment,” said Julie Schallhorn, MD, as she introduced the articles in the Cornea section of the issue.
Biologics may dominate in the retina subspecialty, but cornea is beginning to see interest with these products as well, especially for immune-mediated or severe ocular surface diseases and even corneal dystrophies. Three physicians spoke to EyeWorld about the topic.
ASCRS Subspecialty Day will take place on Friday, April 10, ahead of the 2026 ASCRS Annual Meeting, and promises exciting content across the fields of cornea, glaucoma, and refractive surgery.
➤ First patient treated with novel crosslinking approach for refractive error ➤ Multisociety working group established to set guidelines for modern IOL classification ➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial ➤ ASCRS news and events
➤ Enrollment complete in Phase 3 trial for wet AMD ➤ Dosing complete in Phase 1/2 trial for retinitis pigmentosa treatment ➤ First patient dosed in gene therapy study for optic nerve disorder ➤ Company news
Get the latest ophthalmology news delivered to your inbox every Friday.